We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+5.68%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$20.9B
AUM Growth
+$2.54B
Cap. Flow
+$1.55B
Cap. Flow %
7.41%
Top 10 Hldgs %
15.24%
Holding
2,978
New
379
Increased
824
Reduced
813
Closed
161

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$798M
2
XOM icon
ExxonMobil
XOM
+$189M
3
CTSH icon
Cognizant
CTSH
+$86.4M
4
MRK icon
Merck
MRK
+$80.6M
5
IART icon
Integra LifeSciences
IART
+$47.9M

Top Sells

Rank Stock Value
1
ATVI
Activision Blizzard
ATVI
+$57.5M
2
PEP icon
PepsiCo
PEP
+$55.1M
3
DG icon
Dollar General
DG
+$49.7M
4
WOOF
VCA Inc.
WOOF
+$48.1M
5
SPG icon
Simon Property Group
SPG
+$45.6M

Sector Composition

Rank Sector Weight
1 Healthcare 17.52%
2 Technology 14.11%
3 Financials 12.07%
4 Industrials 10.58%
5 Consumer Discretionary 9.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STAY
2351
DELISTED
Extended Stay America, Inc. Paired Share Unit
STAY
$0 ﹤0.01%
33
-66
-67% -$1.09K
WDR
2352
DELISTED
Waddell & Reed Financial, Inc.
WDR
$0 ﹤0.01%
25
-39
-61% -$714
DL
2353
DELISTED
China Distance Education Holdings Limited
DL
$0 ﹤0.01%
97
AIG.WS
2354
DELISTED
American International Group, Inc.
AIG.WS
$0 ﹤0.01%
46
-160
-78% -$3.6K
LN
2355
DELISTED
LINE Corporation
LN
-5,836
Closed -$198K
BITA
2356
DELISTED
Bitauto Holdings Limited
BITA
$0 ﹤0.01%
36
HTZ
2357
DELISTED
Hertz Global Holdings, Inc.
HTZ
$0 ﹤0.01%
7
-41
-85% -$744
CETV
2358
DELISTED
Central European Media Enterprises Ltd
CETV
-878
Closed -$2K
DNR
2359
DELISTED
Denbury Resources, Inc.
DNR
-106,600
Closed -$392K
PTLA
2360
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
-300
Closed -$6K
AGN
2361
DELISTED
Allergan plc
AGN
-5,883
Closed -$1.23M
CYOU
2362
DELISTED
Changyou.com Limited American Depositary Share
CYOU
$0 ﹤0.01%
30
GM.WS.B
2363
DELISTED
General Motors Company
GM.WS.B
$0 ﹤0.01%
+5
New +$94
LABL
2364
DELISTED
Multi-Color Corp
LABL
$0 ﹤0.01%
+7
New +$521
GPIC
2365
DELISTED
Gaming Partners International Corporation
GPIC
-1,031
Closed -$12K
CYHHZ
2366
DELISTED
Community Health Systems, Inc. Series A Contingent Value Rights
CYHHZ
$0 ﹤0.01%
1,002
FBR
2367
DELISTED
Fibria Celulose Sa
FBR
$0 ﹤0.01%
139
OCLR
2368
DELISTED
Oclaro Inc.
OCLR
$0 ﹤0.01%
+100
New +$939
NWY
2369
DELISTED
New York & Co Inc
NWY
$0 ﹤0.01%
+180
New +$396
PF
2370
DELISTED
Pinnacle Foods, Inc.
PF
-1,217
Closed -$65K
PNK
2371
DELISTED
Pinnacle Entertainment Inc.
PNK
$0 ﹤0.01%
2
EGLT
2372
DELISTED
Egalet Corporation
EGLT
$0 ﹤0.01%
150
JASO
2373
DELISTED
JA Solar Holdings, Co., Ltd
JASO
$0 ﹤0.01%
95
YGE
2374
DELISTED
Yingli Green Energy Holding Comp
YGE
$0 ﹤0.01%
57
FINL
2375
DELISTED
Finish Line
FINL
-19,443
Closed -$365K

Similar funds

Glenmede Trust's Q1 2017 Portfolio in Review

As of Q1 2017, Glenmede Trust held 2,978 positions worth $20.9B, up 14% from $18.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Glenmede Trust deployed $1.55B of net new capital in Q1 2017, opening 379 new positions and adding to 824 existing holdings. Its largest new stake was Pebblebrook Hotel Trust: 1,454,685 shares worth $42.4M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 13% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Activision Blizzard, an estimated $57.5M trimmed.

  • Glenmede Trust's largest Q1 2017 buy was Pebblebrook Hotel Trust: 1,454,685 shares worth $42.4M.
  • Glenmede Trust added most to Johnson & Johnson in Q1 2017, an estimated $798M increase.
  • Glenmede Trust's biggest Q1 2017 reduction was Activision Blizzard, cutting an estimated $57.5M.
  • Glenmede Trust fully exited Cynosure, Inc. Class A in Q1 2017, selling an estimated $22.5M.
  • Glenmede Trust's ten largest holdings make up 15% of its $20.9B portfolio in Q1 2017.
  • Glenmede Trust opened 379 new positions and closed 161 in Q1 2017.
  • Glenmede Trust's portfolio value rose 14% quarter-over-quarter to $20.9B.

Based on Glenmede Trust's 13F filing for Q1 2017, filed 15 May 2017.